Opioid Use Disorder -Global Market Status and Trend Report 2013-2023
Table of Contents
Chapter 1 Overview of Opioid Use Disorder
- 1.1 Definition of Opioid Use Disorder in This Report
- 1.2 Commercial Types of Opioid Use Disorder
- 1.2.1 Buprenorphine
- 1.2.2 Methadone
- 1.2.3 Naltrexone
- 1.3 Downstream Application of Opioid Use Disorder
- 1.3.1 Moderate Pain Treatment
- 1.3.2 Severe Pain Treatment
- 1.4 Development History of Opioid Use Disorder
- 1.5 Market Status and Trend of Opioid Use Disorder 2013-2023
- 1.5.1 Global Opioid Use Disorder Market Status and Trend 2013-2023
- 1.5.2 Regional Opioid Use Disorder Market Status and Trend 2013-2023
Chapter 2 Global Market Status and Forecast by Regions
- 2.1 Market Development of Opioid Use Disorder 2013-2017
- 2.2 Production Market of Opioid Use Disorder by Regions
- 2.2.1 Production Volume of Opioid Use Disorder by Regions
- 2.2.2 Production Value of Opioid Use Disorder by Regions
- 2.3 Demand Market of Opioid Use Disorder by Regions
- 2.4 Production and Demand Status of Opioid Use Disorder by Regions
- 2.4.1 Production and Demand Status of Opioid Use Disorder by Regions 2013-2017
- 2.4.2 Import and Export Status of Opioid Use Disorder by Regions 2013-2017
Chapter 3 Global Market Status and Forecast by Types
- 3.1 Production Volume of Opioid Use Disorder by Types
- 3.2 Production Value of Opioid Use Disorder by Types
- 3.3 Market Forecast of Opioid Use Disorder by Types
Chapter 4 Global Market Status and Forecast by Downstream Industry
- 4.1 Demand Volume of Opioid Use Disorder by Downstream Industry
- 4.2 Market Forecast of Opioid Use Disorder by Downstream Industry
Chapter 5 Market Driving Factor Analysis of Opioid Use Disorder
- 5.1 Global Economy Situation and Trend Overview
- 5.2 Opioid Use Disorder Downstream Industry Situation and Trend Overview
Chapter 6 Opioid Use Disorder Market Competition Status by Major Manufacturers
- 6.1 Production Volume of Opioid Use Disorder by Major Manufacturers
- 6.2 Production Value of Opioid Use Disorder by Major Manufacturers
- 6.3 Basic Information of Opioid Use Disorder by Major Manufacturers
- 6.3.1 Headquarters Location and Established Time of Opioid Use Disorder Major Manufacturer
- 6.3.2 Employees and Revenue Level of Opioid Use Disorder Major Manufacturer
- 6.4 Market Competition News and Trend
- 6.4.1 Merger, Consolidation or Acquisition News
- 6.4.2 Investment or Disinvestment News
- 6.4.3 New Product Development and Launch
Chapter 7 Opioid Use Disorder Major Manufacturers Introduction and Market Data
- 7.1 Orexo
- 7.1.1 Company profile
- 7.1.2 Representative Opioid Use Disorder Product
- 7.1.3 Opioid Use Disorder Sales, Revenue, Price and Gross Margin of Orexo
- 7.2 Camurus
- 7.2.1 Company profile
- 7.2.2 Representative Opioid Use Disorder Product
- 7.2.3 Opioid Use Disorder Sales, Revenue, Price and Gross Margin of Camurus
- 7.3 Hikma Pharmaceuticals
- 7.3.1 Company profile
- 7.3.2 Representative Opioid Use Disorder Product
- 7.3.3 Opioid Use Disorder Sales, Revenue, Price and Gross Margin of Hikma Pharmaceuticals
- 7.4 Alkermes
- 7.4.1 Company profile
- 7.4.2 Representative Opioid Use Disorder Product
- 7.4.3 Opioid Use Disorder Sales, Revenue, Price and Gross Margin of Alkermes
- 7.5 Indivior
- 7.5.1 Company profile
- 7.5.2 Representative Opioid Use Disorder Product
- 7.5.3 Opioid Use Disorder Sales, Revenue, Price and Gross Margin of Indivior
- 7.6 Titan Pharmaceuticals
- 7.6.1 Company profile
- 7.6.2 Representative Opioid Use Disorder Product
- 7.6.3 Opioid Use Disorder Sales, Revenue, Price and Gross Margin of Titan Pharmaceuticals
- 7.7 MediciNova
- 7.7.1 Company profile
- 7.7.2 Representative Opioid Use Disorder Product
- 7.7.3 Opioid Use Disorder Sales, Revenue, Price and Gross Margin of MediciNova
- 7.8 Teva Pharmaceuticals
- 7.8.1 Company profile
- 7.8.2 Representative Opioid Use Disorder Product
- 7.8.3 Opioid Use Disorder Sales, Revenue, Price and Gross Margin of Teva Pharmaceuticals
- 7.9 Omeros
- 7.9.1 Company profile
- 7.9.2 Representative Opioid Use Disorder Product
- 7.9.3 Opioid Use Disorder Sales, Revenue, Price and Gross Margin of Omeros
Chapter 8 Upstream and Downstream Market Analysis of Opioid Use Disorder
- 8.1 Industry Chain of Opioid Use Disorder
- 8.2 Upstream Market and Representative Companies Analysis
- 8.3 Downstream Market and Representative Companies Analysis
Chapter 9 Cost and Gross Margin Analysis of Opioid Use Disorder
- 9.1 Cost Structure Analysis of Opioid Use Disorder
- 9.2 Raw Materials Cost Analysis of Opioid Use Disorder
- 9.3 Labor Cost Analysis of Opioid Use Disorder
- 9.4 Manufacturing Expenses Analysis of Opioid Use Disorder
Chapter 10 Marketing Status Analysis of Opioid Use Disorder
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.1.3 Marketing Channel Development Trend
- 10.2 Market Positioning
- 10.2.1 Pricing Strategy
- 10.2.2 Brand Strategy
- 10.2.3 Target Client
- 10.3 Distributors/Traders List
Chapter 11 Report Conclusion
Chapter 12 Research Methodology and Reference
- 12.1 Methodology/Research Approach
- 12.1.1 Research Programs/Design
- 12.1.2 Market Size Estimation
- 12.1.3 Market Breakdown and Data Triangulation
- 12.2 Data Source
- 12.2.1 Secondary Sources
- 12.2.2 Primary Sources
Report Summary
Opioid Use Disorder -Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Opioid Use Disorder industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Opioid Use Disorder 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Opioid Use Disorder worldwide, with company and product introduction, position in the Opioid Use Disorder market
Market status and development trend of Opioid Use Disorder by types and applications
Cost and profit status of Opioid Use Disorder , and marketing status
Market growth drivers and challenges
The report segments the global Opioid Use Disorder market as:
Global Opioid Use Disorder Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Opioid Use Disorder Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Buprenorphine
Methadone
Naltrexone
Global Opioid Use Disorder Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Moderate Pain Treatment
Severe Pain Treatment
Global Opioid Use Disorder Market: Manufacturers Segment Analysis (Company and Product introduction, Opioid Use Disorder Sales Volume, Revenue, Price and Gross Margin):
Orexo
Camurus
Hikma Pharmaceuticals
Alkermes
Indivior
Titan Pharmaceuticals
MediciNova
Teva Pharmaceuticals
Omeros
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.